CTOs on the Move

FibroGen

www.fibrogen.com

 
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.fibrogen.com
  • 409 Illinois St
    San Francisco, CA USA 94158
  • Phone: 415.978.1200

Executives

Name Title Contact Details
Curtis Golston
Director IT Operations Profile

Funding

FibroGen raised $126.02M on 07/09/2016

Similar Companies

Alpha Lion

Inspiring SuperHumans All Over The World to Achieve Their Dream Physique and Dream Lifestyle.

Lake Shore Inn Nursing Home

Lake Shore Inn Nursing Home is a Waseca, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TeleDiagnostic Systems

TeleDiagnostic Systems is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Anchor Network

Healthcare Anchor Network is a collaboration of over 65 healthcare systems in the United States that are committed to leveraging their institutional assets to improve health and well-being by addressing economic and racial inequities in the communities...